Raphael Pharmaceutical Inc.
RAPH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5 | $17 | $32 | $34 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5 | $16 | $31 | $34 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$1 | -$3 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$1 | -$3 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.081 | -0.08 | -0.23 | -0.1 |
| % Growth | -1.1% | 65% | -130% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$1 |